Tivozanib in Treating Patients With Liver Cancer That Is Metastatic or Cannot Be Removed by Surgery
Clinical trial NCT01835223 · COMPLETED
Trial details
- NCT number
- NCT01835223
- Sponsor
- Roswell Park Cancer Institute
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-07-11
- Primary completion
- 2018-12-24
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.